Following the 2004 spin-out of AB-BIOTICS from the University Autònoma of Barcelona (UAB), our initial focus was on applying innovative technology to help cheese makers differentiate their products through biotechnology. This quickly expanded to other areas of microbiology, focused on developing novel probiotics and specialty dietary supplements.
By investing in the development of a large, proprietary bank of wild-type bacterial strains (over 550), AB-BIOTICS has developed a pipeline of products with novel, patentable performance characteristics. Our pipeline includes a range of proprietary supplements designed to improve health – from products that can lower the risk of cardiovascular disease to those that can help in the management of diabetes. Our pipeline covers the development spectrum from marketed product, to proof-of-concept, and includes products that have been licensed to global food and pharmaceutical companies.
To support our internal product development, we have leveraged our growing technical microbiology expertise to expand into providing contract R&D Project Management services to the nutriceutical and pharmaceutical industries.
Click on the names below to learn more about each of our products
|AB-INTIMUS ®||AB-GINGIBAL ®||AB-LIFE ®|
|AB-HALITOSIS ®||AB-PYLORIOSIS ®||AB-COLIC ®|
|AB-PROBIOSIS ®||AB-FORTIS ®||AB-VITAMIN-K ®|
|AB-I3.1 ®||AB-RADIOBAL ®||AB-ENHANCER ®|